Trial intelligence / Profile preview

Huangqi injection for acute decompensated chronic heart failure

ChiCTR-TRC-08000257Phase 4Completed

Sponsor
Guangzhou University of Chinese Medicine
Start
Dec 2007
Countries
1
01

Overview

Phase 4, randomised trial of astragalus membranaceus in chronic heart failure (CHF) (2 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoints: Tei index by echocardiography, Left ventricular ejection fraction and 1 more. Started Dec 2007; status: completed.

02

Drugs

astragalus membranaceus
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on ChiCTR-TRC-08000257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call